An interventional study of New clear expander and Hyrax expander in Malocclusion and Narrow Maxilla, sponsored by University of Baghdad. Recruiting at 1 site in Iraq. Open to participants aged 10 Years to 14 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-22.
Sponsored by University of Baghdad · Not applicable, Interventional, and Treatment
This study will be conducted to evaluate the effectiveness of a clear expander fabricated from 2-mm biocompatible polyethylene terephthalate glycol (PETG) thermoforming material integrated with an expansion screw in achieving dental and skeletal expansion in adolescent patients, compared with the conventional Hyrax expander.
This will be a multicenter randomize clinical trial with two-arm parallel groups, and will be conducted at the Department of Orthodontics, College of Dentistry, University of Baghdad, as well as different specialized dental centers affiliated with the Iraqi Ministry of Health, and some private clinics.
The sample size will be calculated based on previous studies with similar aim to measure the skeletal expansion. A minimum sample size of 17 patients was required, and in order to account for a 15% dropout, a total of 20 patients will be recruited for each group (new clear expander and hyrax expander). The amount of 2.5 mm or greater of maxillary sutural opening will be considered clinically effective.
Two randomizations will be employed, one for the expander type and the other for the cleaning method of the new expander, a computer random generator will be used to develop a simple randomization with an equal allocation ratio (1:1) and without stratification.
Data Collection and Measurements will be include, CBCT evaluation, Intraoral scan of the maxillary arch evaluation, overjet and overbite, CBCT-derived cephalometric images will be used to measure the maxillary mandibular plane angle, Microbial evaluation after using two different methods for cleaning the new clear expander and at the end of the treatment, the patient will be asked to fill out a questionnaire about the treatment, giving information about their experience and satisfaction during treatment.
Data will be analyzed using the Statistical Package for Social Sciences for Windows, version 26.0, including Descriptive Statistics 9numbers, frequencies, percentages, mean, median, and standard deviations), Reliability Statistics (an intraclass correlation coefficient), and Inferential Statistics (Levene's test, Shapiro Wilk test, Paired samples t-test and Independent samples t-test).
323 studies on the registry are indexed under Malocclusion; 85 are open to participants now.
This study's planned enrollment of 40 is close to the median of 37 across 242 interventional studies indexed under Malocclusion.
Browse Malocclusion studies →University of Baghdad is the lead sponsor of 170 studies on the registry; 69 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
After obtaining the 3D-printed maxillary dental cast, a 2 mm PETG (rigid) thermoforming material (Leone® S.p.A., Florence, Italy) will be adapted separately to the maxillary cast using a pressure molding vacuum machine. The clear appliance will then be trimmed and finished. Depending on the degree of maxillary constriction, a Leone® Standard or universal expansion screw (Leone® S.p.A.,Florence, Italy) measuring 6-9 mm will be incorporated into the appliance and positioned in the midline of the maxillary cast after splitting the appliance midpalatally embedded in acrylic composed from Methyl methacrylate monomer and Methyl methacrylate polymer Orthocryl® liquid (monomer), and Orthocryl® EQ-powder (polymer) (Dentaurum GmbH \& Co. KG, Ispringen, Germany)
Device: New clear expander
After obtaining the 3D-printed maxillary dental cast, patients will be treated with a Hyrax expander using a rapid expander from Leone® S.p.A., Florence, Italy, cemented in the upper first premolars and first molars. If the first premolars had not yet erupted, the Hyrax expander will be cemented in the upper first permanent molars only.
Device: Hyrax expander
All patients with a clear expander will be instructed to wear the appliance 24 hours a day, except during eating and cleaning. The expander will be activated twice daily (0.2 mm per turn). Patients will be provided with an instruction brochure and advised to use a reminder to ensure compliance. The expansion will continue until the desired amount of the maxillary arch expansion occurs when the maxillary first molars' palatal cusps occlude the lingual side of the mandibular first molar buccal cusps to overcome the expected relapse due to the elasticity of the palatal soft tissue.
The activation protocol for the Hyrax expander will be the same in all patients, twice daily (0.2 mm per turn). The expansion will continue until the desired amount of the maxillary arch expansion occurs when the maxillary first molars' palatal cusps occlude the lingual side of the mandibular first molar buccal cusps to overcome the expected relapse due to the elasticity of the palatal soft tissue.
CBCT evaluation
Skeletal and dentoalveolar measurements will be assessed using cone-beam computed tomography (CBCT). Skeletal measurements will include nasal width, midpalatal suture gap, and palatal height, measured in millimeters (mm). Dentoalveolar measurements will include vertical dental heights and maxillary width measured in millimeters (mm), as well as dental inclination measured in degrees (°). All measurements will be obtained from CBCT images using dedicated three-dimensional imaging analysis software.
Time frame: pre-treatment (T0) and immediately post-treatment (T1) around one to two months
Intraoral scan of the maxillary arch evaluation
Maxillary transverse dental measurements will be assessed using a digital intraoral scan. The parameters evaluated will include intercanine width, interpremolar width, intermolar width, and intermolar transpalatal width, all measured in millimeters (mm) using three-dimensional digital dental model analysis software.
Time frame: pre-treatment (T0) and post-treatment (T1) around one to two months
Clinical evaluation
Overjet and overbite will be evaluated clinically using a calibrated orthodontic ruler, with measurements recorded in millimeters (mm).
Time frame: pre-treatment (T0) and immediately post-treatment (T1) around one to two months
Cephalometric analysis
CBCT-derived cephalometric images will be used to measure the maxillary mandibular plane angle in degrees (°) to evaluate the vertical relationship using cephalometric analysis software.
Time frame: pre-treatment (T0) and immediately post-treatment (T1) around one to two months
Microbial evaluation
Patients will be allocated into two groups according to the cleaning method: brushing with a toothbrush and aligner foam (China) or using Efferdent cleaning tablets (USA). Biofilm samples will be collected using sterile swabs with Amies transport medium (Boen Healthcare Co., Ltd., China). The outcome measure will be bacterial biofilm accumulation, assessed by bacteriological analysis based on bacterial colony counting, expressed as colony-forming units per milliliter (CFU/ml).
Time frame: after one month.
Patient satisfaction with the appliance
At the end of treatment, patient-reported experience and satisfaction will be assessed using a structured questionnaire. Responses will be recorded as questionnaire scores using a 3-point Likert-type scale.
Time frame: around one to two months
Plan to share: No
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.